selected scholarly activity
-
books
-
chapters
-
conferences
- Factors associated with suicide risk in young women with premenstrual dysphoric disorder: A population-based study. Trends in Psychiatry and Psychotherapy. 114-114. 2024
- Perinatal factors as risk factors of bipolar disorder onset in young adulthood: a 22-year birth cohort. Revista Brasileira de Psiquiatria. e20233338. 2024
- Biological rhythms disruption mediates the association between mother's diagnosis of bipolar disorder and children's emotional and behavioral problems. Bipolar Disorders. 55-55. 2023
- Early identification of bipolar disorder among young adults - a 22-year community birth cohort. Bipolar Disorders. 14-14. 2023
- Evaluation of mesencephalic astrocyte-derived neurotrophic factor serum levels in mood disorders. Bipolar Disorders. 58-58. 2023
- Speech Biomarkers in Mood Disorders: A Cross-Sectional Study. Biological Psychiatry. S197-S197. 2023
- Predictors of illicit substance abuse/dependence during young adulthood: A machine learning approach. Journal of Psychiatric Research. 168-173. 2023
- Tumor necrosis factor alpha and its association with bipolar disorder: A systematic review and meta-analysis. Bipolar Disorders. 31-31. 2022
- Investigating biological rhythms disruptions across the menstrual cycle in women with comorbid bipolar disorder and premenstrual dysphoric disorder. Archives of Women's Mental Health. 345-353. 2022
- Functional and cognitive impairment in the first episode of depression: A systematic review. Acta Psychiatrica Scandinavica. 156-185. 2022
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study. Psychiatry Research. 2021
- Bipolar disorder and frontotemporal dementia: A systematic review. Bipolar Disorders. 77-77. 2021
- Lifestyle predictors of depression and anxiety during COVID-19: A machine learning approach. Bipolar Disorders. 56-56. 2021
- Mixed episodes and suicide risk: A community sample of young adults. Bipolar Disorders. 100-100. 2021
- Relationship between childhood trauma and inflammatory biomarkers in individuals with current depressive episodes. Bipolar Disorders. 76-76. 2021
- Early Life Stress is a Risk Factor for Bipolar Disorder: A Prospective Cohort Study of Young Adults. Biological Psychiatry. S315-S315. 2021
- P.250 Prediction of bipolar disorder four years before onset in a 22-year population-based birth cohort using advanced machine learning techniques. European Neuropsychopharmacology. S142-S143. 2020
- Biological rhythms disruption in comorbid bipolar disorder and premenstrual dysphoric disorder. Bipolar Disorders. 102-102. 2020
- Clozapine in bipolar disorder: A systematic review and meta-analysis. Bipolar Disorders. 81-81. 2020
- Cognitive complaints in mood disorders: A cross-sectional study. Bipolar Disorders. 93-93. 2020
- Functional impairment in a community sample of euthymic drug-free young adults with bipolar disorder. Bipolar Disorders. 74-75. 2020
- Functional impairment, biomarkers, and neuroprogression in bipolar disorder. Bipolar Disorders. 46-46. 2020
- Resilience as a mediator factor in the relationship between childhood trauma and mood disorder: A community sample of young adults. Bipolar Disorders. 119-119. 2020
- Risk of dementia in bipolar disorder and the interplay of lithium: A systematic review and meta-analyses. Bipolar Disorders. 107-107. 2020
- S149. Gene Expression in Dorsolateral Prefrontal Cortex: A Master Regulator Analysis of Major Psychiatric Disorders. Biological Psychiatry. S354-S354. 2019
- Explicit emotional memory in major depressive disorder during euthymia. Bipolar Disorders. 150-151. 2019
- Intracortical Myelin as a novel neurobiological correlate of psychosocial functioning in bipolar I disorder. Bipolar Disorders. 76-77. 2019
- Lifetime cocaine use predicts conversion from major depressive disorder to bipolar disorder: A prospective 3-year follow-up study. Bipolar Disorders. 95-96. 2019
- P2X7R participates in the pathophysiology of mania: A preclinical study. Bipolar Disorders. 71-71. 2019
- Predicting conversion to mood disorders in a cohort of bipolar offspring. Bipolar Disorders. 68-68. 2019
- Predictors of cognitive heterogeneity in a transcultural sample of individuals with bipolar disorder: A machine-learning approach. Bipolar Disorders. 75-76. 2019
- The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study. Bipolar Disorders. 78-79. 2019
- Trauma, cocaine use and female sex predict transition from major depression to bipolar disorder. Bipolar Disorders. 56-56. 2019
- S118. Emotional Memory Changes and its Correlation With Severity in Bipolar Disorder. Biological Psychiatry. S393-S393. 2018
- A biomarkers signature differentiates unipolar from bipolar depression. Bipolar Disorders. 34-34. 2018
- Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Bipolar Disorders. 98-98. 2018
- Emotional memory in bipolar disorder and major depressive disorder: a preliminary report. Bipolar Disorders. 102-103. 2018
- The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder. Bipolar Disorders. 78-78. 2018
- The impact of big data analytics on bipolar disorder diagnosis. Bipolar Disorders. 23-24. 2018
- The impact of body mass index on gene expression of reelin pathway mediators in individuals with Schizophrenia and Mood disorders: a postmortem study. Bipolar Disorders. 124-124. 2018
- The transcription factor of the early growth response gene-3 (EGR-3) system as a target for immune intervention in bipolar disorder. Bipolar Disorders. 32-32. 2018
- Prediction of Functional Impairment Among Patients With Bipolar Disorder - A Machine Learning Approach. Neuropsychopharmacology. S9-S9. 2017
- Clinical correlates of early-onset bipolar I disorder. European Neuropsychopharmacology. S823-S823. 2017
- DIFFERENTIAL EXPRESSION OF TRANSCRIPTION FACTORS IN THE PREFRONTAL CORTEX OF INDIVIDUALS WITH BIPOLAR DISORDER. European Neuropsychopharmacology. S212-S212. 2017
- Predicting functional impairment in bipolar disorder: a pilot study with a machine learning approach. European Neuropsychopharmacology. S822-S823. 2017
- 509. EGR3 in Bipolar Disorder: Preliminary Results of an in Vitro Study for Validation of Bioinformatics Findings. Biological Psychiatry. S207-S207. 2017
- A 24-week randomized, placebo-controlled trial of adjunctive tianeptine in the maintenance treatment of bipolar disorder. Bipolar Disorders. 119-119. 2017
- Biomarker signatures of bipolar disorder and schizophrenia. Bipolar Disorders. 98-99. 2017
- Clinical outcomes in bipolar disorder and childhood trauma: a community sample of young adults. Bipolar Disorders. 129-129. 2017
- Clinical outcomes in subthreshold bipolar disorder: a community sample of young adults. Bipolar Disorders. 128-129. 2017
- Cognitive performance and mood disorders in a community sample of young adults. Bipolar Disorders. 104-104. 2017
- Concordance and discrepancy between subjective and objective cognitive assessment in bipolar disorder: what is influencing this discrepancy?. Bipolar Disorders. 109-109. 2017
- Serum of bipolar patients induces pro-inflammatory activation of macrophages. Bipolar Disorders. 122-122. 2017
- The Brazilian research network in bipolar disorder: main findings from the first 7 years of collaborative studies. Bipolar Disorders. 139-139. 2017
- Transdiagnostic aspects of peripheral biomarkers in major psychiatric disorders: a systematic review. Bipolar Disorders. 126-127. 2017
- Serum of Bipolar Patients Induces Pro-inflammatory Activation of Macrophages. European psychiatry. S114-S114. 2017
- Clinical correlates of general medical comorbidities in bipolar disorder. Bipolar Disorders. 84-84. 2016
- Inflammation and mitochondrial dysfunction in bipolar disorder. Bipolar Disorders. 32-32. 2016
- Inflammatory Cytokines and Functioning in Drug-free Subjects With Bipolar Disorder. Biological Psychiatry. 232S-232S. 2016
- P.2.c.008 Cell therapy as a strategy for the treatment of bipolar disorder: preliminary results of a study using an animal model of mania. European Neuropsychopharmacology. S410-S410. 2015
- P.2.d.015 Short telomeres in subjects with remitted bipolar disorder. European Neuropsychopharmacology. S419-S420. 2015
- Microglial activation and inflammation in bipolar disorder. Bipolar Disorders. 22-22. 2015
- A Meta-analysis and Meta-regression of Immune Activation in Posttraumatic Stress Disorder. Biological Psychiatry. 61S-62S. 2015
- Assessment of Serum Biomarkers in Siblings of Patients with Bipolar Disorder. Biological Psychiatry. 383S-383S. 2015
- Damage-Associated Molecular Patterns, Immune Activation and Neuroprogression in Bipolar Disorder. Biological Psychiatry. 2015
- Damage-associated Molecular Patterns in Bipolar Disorder. Biological Psychiatry. 412S-413S. 2015
- Identifying and Validating Distinct Clinical Phenotypes in Bipolar Disorders Using Neurocognitive Data, Neuroimaging Scans and Machine Learning. Biological Psychiatry. 2015
- Mesenchymal Stem Cells as a New Therapy for Bipolar Disorder: Preliminary Results of an In Vitro Study. Biological Psychiatry. 2015
- Peripheral Inflammation and Impulsivity in Bipolar Disorder. Biological Psychiatry. 412S-412S. 2015
- Predictors of Psychiatric Readmission Among Bipolar Disorder Patients. Biological Psychiatry. 2015
- Smaller Hippocampal Volumes and Verbal Learning Task Deficits in Bipolar Patients with BDNF val66met (rs6265) Gene Polymorphism. Biological Psychiatry. 2015
- Damage-associated Molecular Patterns in Bipolar Disorder. Neuropsychopharmacology. S573-S573. 2014
- P.2.c.004 The receptor P2X7 participates in the amphetamine-induced increase of a proinflammatory environment in an animal model of mania. European Neuropsychopharmacology. S409-S410. 2014
- P.2.c.005 Use of mesenchymal stem cells as a novel treatment for bipolar disorder: preliminary results of an in vitro study. European Neuropsychopharmacology. S410-S410. 2014
- P.2.c.009 Epigenetically-induced modulation of the stress axis associated with the progression of bipolar disorder. European Neuropsychopharmacology. S412-S413. 2014
- P.2.d.033 Staging bipolar disorder: biological, clinical and functional correlates. European Neuropsychopharmacology. S432-S433. 2014
- Impact on biomarkers of a comprehensive rehabilitation program in bipolar disorder (PRISMA): A multimodal approach. International Journal of Neuropsychopharmacology. 93-93. 2014
- C-Reactive Protein Levels in Bipolar Disorder: A Review and Meta-analysis. Biological Psychiatry. 41S-42S. 2014
- Dexamethasone Suppression Test in Early- and Late- Stage Patients with Bipolar Disorder Type I and Siblings. Biological Psychiatry. 114S-115S. 2014
- Glucocorticoid Receptor Sensitivity and FKBP51 Levels in Patients with Bipolar Disorder Type I and Siblings. Biological Psychiatry. 115S-115S. 2014
- Increased Insulin-Like Growth Factor (IGF-1) Serum Levels in Bipolar Disorder. Biological Psychiatry. 42S-42S. 2014
- Modulation of Receptor Activated by Damage Associated Molecular Pattern (DAMP) Modifies Behavior in a Pharmacological Model of Mania - A Possible Microglial Involvement. Biological Psychiatry. 314S-314S. 2014
- Multimodal Intervention Program in Bipolar I Disorder and Schizophrenia: Prisma. Biological Psychiatry. 261S-261S. 2014
- Neurosteroids and Psychiatric Disorders. Biological Psychiatry. 114S-114S. 2014
- Prefrontal Cortex Volume in Patients with Bipolar Disorder is Correlated with Functioning in Daily-Life Activities. Biological Psychiatry. 237S-237S. 2014
- Use of Cell Therapy as a Promising Strategy for the Treatment of Bipolar Disorder: Preliminary Results of an In Vitro Study. Biological Psychiatry. 182S-183S. 2014
- Poster #M85 VERBAL EPISODIC MEMORY IMPAIRMENT ALONG THE COURSE OF SCHIZOPHRENIA AND BIPOLAR DISORDER. Schizophrenia Research. S220-S221. 2014
- Abstracts. Bipolar Disorders. 71-132. 2014
- Bipolar disorder vs disruptive mood dysregulation disorder: MRI studies. Bipolar Disorders. 100-100. 2014
- Correlation between peripheral BDNF levels and hippocampus volume in children and adolescents with bipolar disorder. Bipolar Disorders. 76-76. 2014
- Hippocampal volumes are correlated to inflammatory markers in early stage bipolar disorder. Bipolar Disorders. 88-89. 2014
- Oxidative stress and inflammation in bipolar disorder: the putative role of activated microglial cells. Bipolar Disorders. 24-24. 2014
- Staging and profiling bipolar disorder: clinical and neurobiological approaches. Bipolar Disorders. 84-84. 2014
- Staging and profiling: complementary approaches to improve treatment. Bipolar Disorders. 59-59. 2014
- Staging bipolar disorder: clinical, biochemical, and functional correlates. Bipolar Disorders. 73-73. 2014
- Cytokines, Oxidative Stress Markers and Brain-Derived Neurotrophic Factor In Fibromyalgia Syndrome. Arthritis and Rheumatism. S57-S57. 2013
- Evaluation of peripheral biomarkers in bipolar and unipolar depression. European Neuropsychopharmacology. S361-S362. 2013
- P.1.g.067 Tianeptine has neuroprotective effects in a differentiated SH-SY5Y human neuroblastoma cell line. European Neuropsychopharmacology. S229-S229. 2013
- P.2.d.009 The predictive role of Val66Met polymorphism on levels of BDNF along treatment of medication-free patients with bipolar disorder. European Neuropsychopharmacology. S367-S368. 2013
- P.2.d.046 C-reactive protein is elevated in bipolar disorder. European Neuropsychopharmacology. S390-S391. 2013
- PLASMA CONCENTRATIONS OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN PATIENTS WITH GENDER IDENTITY DISORDER. Journal of Sexual Medicine. 332-332. 2013
- Association of obesity with reduced hippocampal volume in bipolar disorder. Bipolar Disorders. 140-140. 2013
- Biomarkers and clinical staging. Bipolar Disorders. 28-28. 2013
- Coping skills and functioning in first-degree relatives of bipolar disorder patients - preliminary data. Bipolar Disorders. 143-143. 2013
- Differential early attachment characteristics in schizophrenic and bipolar disorder patients. Bipolar Disorders. 142-142. 2013
- Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder: preliminary results. Bipolar Disorders. 72-72. 2013
- Early life trauma, inflammation and mood disorders in young adults from the general population. Bipolar Disorders. 39-39. 2013
- Gender differences in bipolar disorder evaluated by inductive logic programming approach. Bipolar Disorders. 112-113. 2013
- How do patients defend themselves from bipolar disorder?. Bipolar Disorders. 105-105. 2013
- Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. Bipolar Disorders. 136-136. 2013
- Inductive logic programming approach analysis in bipolar disorder - pilot study. Bipolar Disorders. 69-69. 2013
- Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. Bipolar Disorders. 68-68. 2013
- Prodromal mood symptoms and inflammatory markers in first-degree relatives of patients with bipolar disorder: preliminary data. Bipolar Disorders. 94-94. 2013
- VaI66Met polymorphism and longitudinal changes in serum brain-derived neurotrophic factor along treatment of medication-free patients with bipolar disorder. Bipolar Disorders. 56-56. 2013
- Increased Protein Oxidative Stress in Siblings of Patients with Schizophrenia. Biological Psychiatry. 291S-291S. 2013
- Verbal Memory Deficit in Siblings of Patients with Schizophrenia. Biological Psychiatry. 171S-171S. 2013
- INTERLEUKIN-6 AS A BIOMARKER OF THE MODEL OF STAGING IN BIPOLAR DISORDER. European psychiatry. 2013
- THE ROLE OF COMORBID ANXIETY DISORDER IN THE OUTCOME OF BIPOLAR I DISORDER. European psychiatry. 2013
- P.2.e.027 Interleukin-6 as a biomarker of the model of staging in bipolar disorder. European Neuropsychopharmacology. S291-S292. 2012
- S.06.04 Staging and biomarkers in bipolar disorders. European Neuropsychopharmacology. S120-S120. 2012
- Brain-Derived Neurotrophic Factor as a Biomarker of Clinical Response: 16-Week Follow-Up Study. Biological Psychiatry. 26S-26S. 2012
- Increase in Cellular Viability in SH-SY5Y Neuroblastoma Cell Line Induced by Incubation with Serum from Euthymic Bipolar Patients. Biological Psychiatry. 215S-215S. 2012
- A nested population-based case-control study on peripheral inflammation markers and brain-derived neurotrophic factor in early-stage mood disorders. Bipolar Disorders. 48-48. 2012
- Analysis of mitochondrial complexes activity in peripheral blood mononuclear cells of bipolar disorder, schizophrenic and healthy subjects. Bipolar Disorders. 80-80. 2012
- BDNF levels in first-degree relatives of patients with bipolar disorder: preliminary data. Bipolar Disorders. 107-107. 2012
- Bipolar disorder treatment: implications from the staging model perspective. Bipolar Disorders. 95-95. 2012
- Brain-Derived Neurotrophic Factor in Juvenile Bipolar Disorder and Attention-Deficit Hyperactivity Disorder: differentiation using BDNF serum levels, and Val66Met. Bipolar Disorders. 48-48. 2012
- Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16-week follow-up study. European Neuropsychopharmacology. S5-S6. 2012
- Clinical characteristics and pattern of drug use in a population of crack cocaine users with and without mood disorders. Bipolar Disorders. 88-88. 2012
- Delay in bipolar disorder treatment is correlated to an adverse course of illness. Bipolar Disorders. 74-75. 2012
- Impact of first-episode polarity on clinical features associated to suicide attempts in bipolar disorder type I patients. Bipolar Disorders. 38-38. 2012
- Role of biomarkers in the staging of bipolar disorder: inflammatory factors and oxidative stress. Bipolar Disorders. 79-79. 2012
- Significance of homocysteine to the cardiovascular risk in bipolar disorder. Bipolar Disorders. 87-87. 2012
- The staging model of bipolar disorder and cognitive functioning: a comparison with patients with schizophrenia. Bipolar Disorders. 75-75. 2012
- BRAIN-DERIVED NEUROTROPHIC FACTOR AS A BIOMARKER OF CLINICAL RESPONSE IN BIPOLAR DISORDER: 16 WEEK FOLLOW-UP STUDY. European psychiatry. 2012
- Association between daily dose of clozapine and levels of brain-derived neurotrophic factor in patients with schizophrenia. Revista Brasileira de Psiquiatria. S35-S35. 2011
- Evaluation of decision-making through the ultimatum game in bipolar disorder. Revista Brasileira de Psiquiatria. S34-S34. 2011
- Lithium and tamoxifen increased the levels of PKA Protein, CREM and BDNF in an animal model of mania d-amphetamine-induced. Revista Brasileira de Psiquiatria. S37-S37. 2011
- Lithium and tamoxifend protect the brain of mice against the increase of GSK-3 and the dicrease of phosphorylation of GSK-3 in an animal model of mania amphetamine-induced. Revista Brasileira de Psiquiatria. S36-S36. 2011
- Memory and BDNF levels in an animal model of mania in early and late stages of bipolar disorder. Revista Brasileira de Psiquiatria. S36-S36. 2011
- Psychometric properties of the FAST scale (Functioning Assessment Short Test) in patients with schizophrenia. Revista Brasileira de Psiquiatria. S41-S41. 2011
- The association between levels of estrogen and BDNF in women with bipolar disorder. Revista Brasileira de Psiquiatria. S34-S34. 2011
- Vulnerability to a Nutritional Deficiency of N-3 Polyunsaturated Fatty Acids (N-3 Pufas) by Exposure to Early Stress - Effects on Behavior and Metabolism. Journal of Developmental Origins of Health and Disease. S66-S66. 2011
- A longitudinal assessment of serum Brain Derived Neurotrophic Factor levels in bipolar patients. Bipolar Disorders. 51-51. 2011
- Clinical characteristics of suicide attempters among bipolar disorder patients - results from the Brazilian Research Consortium for Bipolar Disorders. Bipolar Disorders. 27-27. 2011
- Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity. Bipolar Disorders. 21-21. 2011
- Comparison of creatine kinase levels in depressed, manic and euthymic patients with bipolar disorder. Bipolar Disorders. 44-44. 2011
- Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder. Bipolar Disorders. 105-105. 2011
- Effects of sodium butyrate on d-amphetamine-induced oxidative stress in the rat brain. Bipolar Disorders. 81-81. 2011
- Gender differences in bipolar disorder: finding from the Brazilian Bipolar Research Network. Bipolar Disorders. 39-40. 2011
- Impact of migraine comorbidity in the clinical course of bipolar disorder. Bipolar Disorders. 32-32. 2011
- Internalized stigma in bipolar disorder type I (INTEST-BD I) project: comparison of internalized stigma in a sample of young adults and chronic outpatients with bipolar disorder type I. Bipolar Disorders. 36-36. 2011
- Low prevalence of alcohol use disorders in Brazilian bipolar disorder patients: results from the Brazilian Bipolar Research Network. Bipolar Disorders. 73-73. 2011
- N-acetyl cysteine (NAC) as an adjunctive therapy for bipolar depression. Bipolar Disorders. 38-38. 2011
- Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Bipolar Disorders. 79-79. 2011
- Serum Brain Derived Neurotrophic Factor and Clozapine Daily Dose in Patients with Schizophrenia: A Positive Correlation. Biological Psychiatry. 282S-282S. 2011
- S.22.02 Alostatic load and oxidative stress in bipolar disorder. European Neuropsychopharmacology. S196-S196. 2010
- Serum Levels of II6, II10 and TNF-Alpha in Patients with Bipolar Disorder in Euthymia and with Schizophrenia: Differences in Pro and Anti-Inflammatory Balance. Biological Psychiatry. 132S-132S. 2010
- Abnormalities in serum chemokines levels in euthymic patients with bipolar disorder. Bipolar Disorders. 10-10. 2010
- Allostatic load in bipolar disorder. Bipolar Disorders. 30-30. 2010
- Attention deficit and psychopathology in children victims of trauma. Bipolar Disorders. 30-30. 2010
- BDNF levels in the rat prefrontal cortex, amygdala and hippocampal CA3 region in an animal model of mania. Bipolar Disorders. 1-2. 2010
- Brain-derived neurotrophic factor as a possible biomarker of bipolar disorder activity. Bipolar Disorders. 19-19. 2010
- Brain-derived neutrotrophic in mania, depression, and euthymia in bipolar disorders: a systematic review and meta-analysis. Bipolar Disorders. 19-19. 2010
- Cognitive assessment in a crack users population with and without mood disorders: a pilot study. Bipolar Disorders. 40-41. 2010
- Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity. Bipolar Disorders. 1-1. 2010
- Comparison of creatine kinase levels in depressed, manic, and euthymic patients with bipolar disorder. Bipolar Disorders. 18-18. 2010
- Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder. Bipolar Disorders. 10-11. 2010
- Complement system in bipolar disorders and schizophrenia: C3 and C4. Bipolar Disorders. 18-19. 2010
- Correlation between serum brain-derived neurotrophic factor and neurotrophin-3 levels in bipolar disorder. Bipolar Disorders. 22-22. 2010
- Decreased cellular viability in SH-SY5Y neuroblastoma cell line induced by incubation with serum from manic bipolar patients. Bipolar Disorders. 15-15. 2010
- Early life stress does not alter global DNA methylation in the striatum of an animal model of mania. Bipolar Disorders. 20-21. 2010
- Effect of mood stabilizers on behavioral and manic-like symptoms secondary to herpes simplex encephalitis: a case report. Bipolar Disorders. 39-39. 2010
- Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. Bipolar Disorders. 39-39. 2010
- Effects of sodium butyrate and tamoxifen on creatine kinase activity in an animal model of mania. Bipolar Disorders. 45-45. 2010
- Functional impairment and disability across mood states in subjects with bipolar disorder. Bipolar Disorders. 47-47. 2010
- Mass spectrometry of synaptosome after treatment with m-amphetamine as a potential means to investigate the pathophysiology of bipolar disorder. Bipolar Disorders. 15-15. 2010
- Neurotrophin-3 is increased in patients with bipolar disorder on and off medication during manic and depressive episodes. Bipolar Disorders. 19-19. 2010
- Psychiatric hospitalizations due to bipolar disorder, major depression disorder, and schizophrenia in Rio Grande do Sul, Brazil. Bipolar Disorders. 59-60. 2010
- Serum thiobarbituric acid reactive substances in bipolar disorder during mania and schizophrenia: a biomarker with possible diagnostic implications. Bipolar Disorders. 20-20. 2010
- Stigma and functioning in patients with bipolar disorders. Bipolar Disorders. 55-56. 2010
- The International Society for Bipolar Disorders (ISBD) Task Force on the Nomenclature of Course and Outcome in Bipolar Disorders. Bipolar Disorders. 53-53. 2010
- Glucocorticoids and systemic toxicity in mood episodes. International Journal of Neuropsychopharmacology. 16-17. 2010
- Glutathione and redox biology in Bipolar Disorder; from pathophysiology to novel treatments. International Journal of Neuropsychopharmacology. 11-11. 2010
- Development and use of a biological rhythm interview. Journal of Affective Disorders. 161-165. 2009
- Brain-derived neurotrophic factor levels and cognitive dysfunction in euthymic bipolar type I patients. Bipolar Disorders. 88-88. 2009
- DNA damage and apoptosis in bipolar and schizophrenia patients. Bipolar Disorders. 16-16. 2009
- Decreased serum brain-derived neurotrophic factor in unmedicated and medicated bipolar patients during manic and depressive episodes. Bipolar Disorders. 65-66. 2009
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Bipolar Disorders. 71-71. 2009
- Predictors of functional impairment in bipolar disorder: clinical factors. Bipolar Disorders. 95-95. 2009
- Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients. Bipolar Disorders. 40-41. 2009
- Brain-derived Neurotrophic Factor and Thiobarbituric Acid Reactive Substances Serum Levels in Chronicaly Medicated Schizophrenic Patients: A Positive Correlation. Biological Psychiatry. 206S-206S. 2009
- Decreased Serum Brain-Derived Neurotrophic Factor in Unmedicated and Medicated Bipolar Patients in Manic and Depressive Episodes. Biological Psychiatry. 132S-132S. 2009
- The Cellular Targets of Oxidative Damage. Biological Psychiatry. 105S-105S. 2009
- ADVANCES IN THE PATHOPHYSIOLOGY OF EPISODE-RELATED COGNITIVE IMPAIRMENT IN BIPOLAR DISORDER. European psychiatry. 2009
- ALLOSTATIC LOAD IN BIPOLAR DISORDER. European psychiatry. 2009
- CLINICAL FACTORS AS PREDICTORS ON FUNCTIONAL IMPAIRMENT IN BIPOLAR DISORDER. European psychiatry. 2009
- WAIST CIRCUMFERENCE AS A SIMPLE AND MEANINGFUL MEANS TO ASSESS INSULIN RESISTANCE AMONG OUTPATIENTS WITH BIPOLAR DISORDER. European psychiatry. 2009
- BDNF PLASMA LEVELS AS A BIOMARKER OF DELIRIUM IN INTENSIVE CARE UNIT PATIENTS.. Critical Care Medicine. A122-A122. 2008
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Bipolar Disorders. 84-84. 2008
- Brain creatine kinase activity in an animal model of mania. Bipolar Disorders. 83-84. 2008
- Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal BDNF protein levels. Bipolar Disorders. 84-85. 2008
- Effects of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Bipolar Disorders. 84-84. 2008
- Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Bipolar Disorders. 85-85. 2008
- Oxidative stress markers in bipolar disorder: A meta-analysis. Bipolar Disorders. 7-7. 2008
- The international society of bipolar disorders task force on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders. 1-1. 2008
- Sleep disturbance induced by amphetamine in a rodent model of mania. Sleep. A319-A319. 2008
- Pathophysiology of cognitive impairment in bipolar disorders. Bipolar Disorders. 3-3. 2007
- Adaptation and validation of the Portuguese version of the functional assessment short test (FAST) in bipolar patients. Bipolar Disorders. 25-25. 2007
- Effects of lithium and valproate on DNA damage and oxidative stress markers in an animal model. Bipolar Disorders. 16-16. 2007
- Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in bipolar disorder during mood episodes and in schizophrenia. Bipolar Disorders. 62-62. 2007
- Functional impairment in patients with remitted bipolar disorder. Bipolar Disorders. 90-90. 2007
- Is neurotrophin-3 involved in bipolar disorder? Data from animal and human studies. Bipolar Disorders. 16-16. 2007
- Psychological interventions for bipolar disorder reduces the recurrence of new episodes: a systematic review and meta-analysis. Bipolar Disorders. 47-47. 2007
- Relevance of allostasis and allostatic load in bipolar disorder. Bipolar Disorders. 47-47. 2007
- Suicidal behavior among bipolar patients at a primary care setting. Bipolar Disorders. 47-48. 2007
- Superior antimanic efficacy of allopurinol compared to dipyridamol and placebo as add-on treatment to lithium in unmedicated bipolar patients during a mania episode: a double-blind placebo-controlled trial. Bipolar Disorders. 69-70. 2007
- The use of clozapine in the treatment of bipolar disorder in a patient with clinical comorbidities. Bipolar Disorders. 37-38. 2007
- A twin-case study of oxidative stress and DNA damage in bipolar disorder. Bipolar Disorders. 64-64. 2006
- Alcohol consumption and suicidal behaviour in bipolar disorder. Bipolar Disorders. 46-46. 2006
- Increased oxidative stress status in bipolar disorder. Bipolar Disorders. 64-64. 2006
- Neuroleptic malignant syndrome associated with olanzapine. Bipolar Disorders. 64-65. 2006
- Quality of life and anxious comorbidity in bipolar patients. Bipolar Disorders. 51-51. 2006
- Serum content of GDNF is increased during manic and depressive episodes. Bipolar Disorders. 65-65. 2006
- Suicidal behavior and anxiety comorbidity affect psychosocial disability in bipolar disorder. Bipolar Disorders. 49-49. 2006
- Increased oxidative stress in submitochondrial particles after chronic d-amphetamine exposure. Biological Psychiatry. 141S-142S. 2006
- Increased oxidative stress in submitochondrial particles after chronic d-amphetamine exposure. Biological Psychiatry. 58S-59S. 2006
- Induction of antioxidant defense enzymes after acute and chronic d-Amphetamine exposure. Biological Psychiatry. 142S-142S. 2006
- A double-blind controlled study of adjunctive allopurinol or dipyridamole to lithium in the treatment of bipolar mania: preliminary results. Bipolar Disorders. 73-73. 2005
- Neurochemical evaluation of neurotrophic factors and markers of neuronal damage during manic episode in drug naive and lithium treated subjects: the possible role of severity of symptoms. Bipolar Disorders. 73-73. 2005
- An open trial of escitalopram in bipolar depression. Biological Psychiatry. 126S-126S. 2005
- Assessment of personality traits in pediatric bipolar disorder using the junior temperament and character inventory. Biological Psychiatry. 126S-126S. 2005
- Females with major depresion exihit lower serotonin synthesis in temporal lobe.. Journal of Nuclear Medicine. 143P-143P. 1999
- Increased affinity of peripheral benzodiazepine receptors in alcoholic liver cirrhosis. Hepatology. P219-P219. 1996
- INTRAPERITONEAL BUT NOT INTRACEREBROVENTRICULAR ADMINISTRATION OF ACTH AND ADRENALINE CAUSES RETROGRADE-AMNESIA. Brazilian Journal of Medical and Biological Research. 461-461. 1983
- Progression of Bipolar Disease to Frontal Dementias: A Systematic Review and Provisional Research Criteria. Journal of Neuropsychiatry and Clinical Neurosciences. 296-296.
-
journal articles
- Childhood maltreatment as a predictor of substance use/misuse among youth: A systematic review and meta-analysis.. Neuroscience and Biobehavioral Reviews. 166:105873. 2024
- Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters. Bipolar Disorders. 26:313-316. 2024
- Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude pilote. Canadian Journal of Psychiatry. 69:242-251. 2024
- Drug Repurposing and Personalized Treatment Strategies for Bipolar Disorder Using Transcriptomic. Revista Brasileira de Psiquiatria. 46:e20233441. 2024
- Premorbid intelligence quotient and school failure as risk markers for bipolar disorder and major depressive disorder. Journal of Psychiatric Research. 169:160-165. 2024
- The S20 Brazilian Mental Health Report for Building a Just World and a Sustainable Planet: Part II. Revista Brasileira de Psiquiatria. 46:e20243707. 2024
- Incidence and risk factors for anxiety disorders in young adults: A population-based prospective cohort study. L'Encephale. 49:572-576. 2023
- Lifestyle in bipolar disorder: A cross-sectional study. Revista de Psiquiatria y Salud Mental. 16:244-250. 2023
- Predicting functional impairment in euthymic patients with mood disorder: A 5-year follow-up. Psychiatry Research. 328:115404-115404. 2023
- Lifestyle interventions for bipolar disorders: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 152:105257-105257. 2023
- Serum BDNF levels increase during early drug withdrawal in alcohol and crack cocaine addiction. Alcohol. 111:1-7. 2023
- Author Correction: Systemic GDF11 attenuates depression-like phenotype in aged mice via stimulation of neuronal autophagy. Nature Aging. 3:1036-1036. 2023
- Atypical antipsychotic-induced mania: A systematic review and meta-analysis. Journal of Affective Disorders. 333:420-435. 2023
- Lifestyle changes during the COVID-19 pandemic in Brazil: results from three consecutive cross-sectional web surveys. BMJ Open. 13:e070328-e070328. 2023
- Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder. International Journal of Bipolar Disorders. 11:22. 2023
- Latent bipolar disorder. The Lancet. 401:2109-2109. 2023
- The HARM models: Predicting longitudinal physical aggression in patients with schizophrenia at an individual level. Journal of Psychiatric Research. 161:91-98. 2023
- Triggers for acute mood episodes in bipolar disorder: A systematic review. Journal of Psychiatric Research. 161:237-260. 2023
- Biological rhythms disruption mediates the association between mother's diagnosis of bipolar disorder and offspring's emotional/behavioral problems. Journal of Affective Disorders. 327:230-235. 2023
- Functional assessment short test (FAST): Self-administration in outpatient mental health settings. Journal of Psychiatric Research. 160:258-262. 2023
- Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review. Australian and New Zealand Journal of Psychiatry. 57:328-343. 2023
- Lifestyle Behaviors, Depression, and Anxiety Among Individuals Living in Canada During the COVID-19 Pandemic. American Journal of Lifestyle Medicine. 17:181-193. 2023
- Childhood trauma, inflammatory biomarkers and the presence of a current depressive episode: Is there a relationship in subjects from a population study?. Journal of Psychiatric Research. 158:255-260. 2023
- Systemic GDF11 attenuates depression-like phenotype in aged mice via stimulation of neuronal autophagy. Nature Aging. 3:213-228. 2023
- Autophagy-based antidepressants?. Revista Brasileira de Psiquiatria. 45:203-204. 2023
- Bipolar disorder triggered by Covid-19 infection. Trends in Psychiatry and Psychotherapy. 45:e20210430. 2023
- Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial. Trends in Psychiatry and Psychotherapy. 45:e20210298. 2023
- Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study. PLoS ONE. 18:e0289059-e0289059. 2023
- Professor Ellis Alindo D'Arrigo Busnello: a humanist and a scientist with a passion for psychiatry and psychopathology. A great mentor of Brazilian scientific postgraduate programs in psychiatry. Revista Brasileira de Psiquiatria. 45:465-466. 2023
- Stigmatized individuals: a case for precision ethics. Trends in Psychiatry and Psychotherapy. 45:e20210354. 2023
- The relationship between objective and subjective cognitive performance to clinical features in bipolar disorder: A 6 years follow-up study. European Journal of Psychiatry. 37:63-66. 2023
- Predicting criminal and violent outcomes in psychiatry: a meta-analysis of diagnostic accuracy. Translational Psychiatry. 12:470. 2022
- Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis and Cannabinoid Research. 7:658-669. 2022
- Prediction of suicide attempts in a prospective cohort study with a nationally representative sample of the US population. Psychological Medicine. 52:2985-2996. 2022
- Association between polarity of first episode and solar insolation in bipolar I disorder. Journal of Psychosomatic Research. 160:110982-110982. 2022
-
Smartphone‐based interventions in bipolar disorder: Systematic review and meta‐analyses of efficacy. A position paper from the International Society for Bipolar Disorders (
ISBD ) Big Data Task Force. Bipolar Disorders. 24:580-614. 2022 - Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis. Translational Psychiatry. 12:332. 2022
- Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series. Journal of Child and Adolescent Psychopharmacology. 32:366-367. 2022
- Inflammatory and oxidative stress markers in post-traumatic stress disorder: a systematic review and meta-analysis. Molecular Psychiatry. 27:3150-3163. 2022
- Network properties of intracortical myelin associated with psychosocial functioning in bipolar I disorder. Bipolar Disorders. 24:539-548. 2022
- Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression. Human Psychopharmacology. 37:e2836. 2022
- Data-driven cognitive phenotypes in subjects with bipolar disorder and their clinical markers of severity. Psychological Medicine. 52:1728-1735. 2022
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. European Neuropsychopharmacology. 60:91-99. 2022
- Investigation of blood-brain barrier disruption in an animal model of mania induced by D-amphetamine. Journal of Affective Disorders Reports. 9:100368-100368. 2022
- Conversion to major neurocognitive disorder after COVID‐19 in a woman with bipolar disorder: A 6‐year longitudinal case report. Bipolar Disorders. 24:451-456. 2022
- Biological underpinnings for the association between substance use and bipolar disorder. Bipolar Disorders. 24:227-228. 2022
- The impact of substance use disorder comorbidity on cognition of individuals with bipolar disorder: A systematic review. Psychiatry Research. 311:114525-114525. 2022
- A qualitative study exploring the process of postmortem brain tissue donation after suicide. Scientific Reports. 12:4710. 2022
- What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines. Journal of Affective Disorders. 298:565-576. 2022
- Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review. Trends in Psychiatry and Psychotherapy. 44. 2022
- Increase in serum brain-derived neurotrophic factor levels during early withdrawal in severe alcohol users. Trends in Psychiatry and Psychotherapy. 44:e20210254. 2022
- Intranasal esketamine and the dawn of precision psychiatry. Revista Brasileira de Psiquiatria. 44:117-118. 2022
- Lifestyle predictors of depression and anxiety during COVID-19: a machine learning approach. Trends in Psychiatry and Psychotherapy. 44:e20210365. 2022
- Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic. Frontiers in Pharmacology. 13:856846. 2022
- Physician suicide demographics and the COVID-19 pandemic. Revista Brasileira de Psiquiatria. 44:124-135. 2022
- Precision Psychiatry: The Future Is Now. Canadian Journal of Psychiatry. 67:21-25. 2022
- Socioeconomic and substance use changes in emerging adults and their relationship with mood disorders in a population-based cohort. Frontiers in Psychiatry. 13:932484. 2022
- Suicide attempt, impulsivity, and exposure to trauma in college students. Revista Brasileira de Psiquiatria. 44:279-288. 2022
- Underage drinking in Brazil: findings from a community household survey. Revista Brasileira de Psiquiatria. 44:257-263. 2022
- 5-year incidence of suicide-risk in youth: A gradient tree boosting and SHAP study. Journal of Affective Disorders. 295:1049-1056. 2021
- A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder. Addiction Science & Clinical Practice. 16:70. 2021
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disorders. 23:767-788. 2021
- Early illness progression in mood disorders: A population-based longitudinal study. Psychiatry Research. 306:114225-114225. 2021
- Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol. BMJ Open. 11:e050453-e050453. 2021
- Lifestyle changes and mental health during the COVID-19 pandemic: A repeated, cross-sectional web survey. Journal of Affective Disorders. 295:173-182. 2021
- Substance use as a risk factor for bipolar disorder: A systematic review. Journal of Psychiatric Research. 144:285-295. 2021
- Bipolar disorder and frontotemporal dementia: A systematic review. Acta Psychiatrica Scandinavica. 144:433-447. 2021
- Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disorders. 23:659-678. 2021
- Differential power of placebo across major psychiatric disorders: a preliminary meta-analysis and machine learning study. Scientific Reports. 11:21301. 2021
- The cumulative effect of multiple dimensions of lifestyle on risky drinking during the Covid-19 pandemic. Preventive Medicine. 150:106718-106718. 2021
- Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder. International Journal of Bipolar Disorders. 9:26. 2021
- Genetic basis of cannabis use: a systematic review. BMC Medical Genetics. 14:203. 2021
- Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic. JAMA network open. 4:e2120603-e2120603. 2021
- Lifestyle in Undergraduate Students and Demographically Matched Controls during the COVID-19 Pandemic in Spain. International Journal of Environmental Research and Public Health. 18:8133-8133. 2021
- Cognitive complaints in individuals recently diagnosed with bipolar disorder: A cross-sectional study. Psychiatry Research. 300:113894-113894. 2021
- Predicting offenses among individuals with psychiatric disorders - A machine learning approach. Journal of Psychiatric Research. 138:146-154. 2021
- History of suicide attempts in patients with bipolar disorder type I: socio-demographic and clinical factors, quality of life and functioning. Nordic Journal of Psychiatry. 75:306-313. 2021
- Sleep alterations in individuals recently diagnosed with bipolar disorder across different mood stages. Psychiatry Research. 299:113824-113824. 2021
- Unveiling the neurobiology of learning and memory: the lifetime accomplishments of Ivan Izquierdo (1937-2021). Revista Brasileira de Psiquiatria. 43:353-354. 2021
- Clozapine for bipolar disorder: What do we know so far and what next?. Bipolar Disorders. 23:115-116. 2021
- Effects of depression and excess body weight on cognition and functioning in young adults: A population-based study. Journal of Affective Disorders. 282:401-406. 2021
- Biological Pathways Associated with Neuroprogression in Bipolar Disorder. Brain Sciences. 11:228-228. 2021
- Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol. BMJ Open. 11:e040349-e040349. 2021
- Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences. PLoS ONE. 16:e0261201-e0261201. 2021
- Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial. General Hospital Psychiatry. 68:97-99. 2021
- Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective. Psychiatry Research. 295:113562-113562. 2021
- Neuroprogression in post-traumatic stress disorder: a systematic review. Trends in Psychiatry and Psychotherapy. 43:167-176. 2021
- The assessment of lifestyle changes during the COVID-19 pandemic using a multidimensional scale. Revista de Psiquiatria y Salud Mental. 14:16-26. 2021
- Translating science into policy: mental health challenges during the COVID-19 pandemic. Revista Brasileira de Psiquiatria. 43:638-649. 2021
- Clinical correlates of high burden of general medical comorbidities in patients with bipolar disorder. Journal of Affective Disorders Reports. 1:100001-100001. 2020
- Early identification of bipolar disorder among young adults – a 22‐year community birth cohort. Acta Psychiatrica Scandinavica. 142:476-485. 2020
- GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol. Systematic Reviews. 9:200. 2020
- Genetic determinants of cannabis use: a systematic review protocol. Systematic Reviews. 9:190. 2020
- Depression, Anxiety, and Lifestyle Among Essential Workers: A Web Survey From Brazil and Spain During the COVID-19 Pandemic. Journal of Medical Internet Research. 22:e22835-e22835. 2020
- The Early Burden of Disability in Individuals With Mood and Other Common Mental Disorders in Ontario, Canada. JAMA network open. 3:e2020213-e2020213. 2020
- Resilience as a mediator factor in the relationship between childhood trauma and mood disorder: A community sample of young adults. Journal of Affective Disorders. 274:48-53. 2020
- Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study. Psychiatry and Clinical Neurosciences. 74:418-423. 2020
- Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population. Diagnostics. 10:419-419. 2020
- Clozapine in bipolar disorder: A systematic review and meta-analysis. Journal of Psychiatric Research. 125:21-27. 2020
- Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta‐analyses. Acta Psychiatrica Scandinavica. 141:510-521. 2020
- Lifestyle behaviours during the COVID‐19 – time to connect. Acta Psychiatrica Scandinavica. 141:399-400. 2020
- Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Australian and New Zealand Journal of Psychiatry. 54:393-401. 2020
- Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal. Revista Brasileira de Psiquiatria. 42:214-217. 2020
- Mixed episodes and suicide risk: A community sample of young adults. Journal of Affective Disorders. 266:252-257. 2020
- Emotional reactivity and explicit emotional memory biases in major depressive disorder during euthymia. Psychiatry Research. 285:112847-112847. 2020
- Gene Regulatory Network of Dorsolateral Prefrontal Cortex: a Master Regulator Analysis of Major Psychiatric Disorders. Molecular Neurobiology. 57:1305-1316. 2020
- P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study. Molecular Neurobiology. 57:1347-1360. 2020
- Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. Bipolar Disorders. 22:13-27. 2020
- Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings. Endocrine, Metabolic and Immune Disorders - Drug Targets. 20:77-86. 2020
- Differentiating irritable mood and disruptive behavior in adults. Trends in Psychiatry and Psychotherapy. 42:375-386. 2020
- Emotional memory in bipolar disorder: Impact of multiple episodes and childhood trauma. Journal of Affective Disorders. 260:206-213. 2020
- Structural and Functional Brain Correlates of Neuroprogression in Bipolar Disorder. Current Topics in Behavioral Neurosciences. 48:197-213. 2020
- Attenuated inflammatory response of monocyte-derived macrophage from patients with BD: a preliminary report. International Journal of Bipolar Disorders. 7:13. 2019
- Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force. Bipolar Disorders. 21:582-594. 2019
- Risk factors for suicidality in patients with panic disorder: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 105:34-38. 2019
- Anxiety disorders in childhood are associated with youth IL-6 levels: A mediation study including metabolic stress and childhood traumatic events. Journal of Psychiatric Research. 115:43-50. 2019
- Differences between unipolar mania and bipolar‐I disorder: Evidence from nine epidemiological studies. Bipolar Disorders. 21:437-448. 2019
- Explicit emotional memory biases in mood disorders: A systematic review. Psychiatry Research. 278:162-172. 2019
- Association between solar insolation and a history of suicide attempts in bipolar I disorder. Journal of Psychiatric Research. 113:1-9. 2019
- Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia. Schizophrenia Research. 208:202-208. 2019
- Clinical outcomes and childhood trauma in bipolar disorder: A community sample of young adults. Psychiatry Research. 275:228-232. 2019
- Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape. Expert Opinion on Therapeutic Targets. 23:327-339. 2019
- Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial. Journal of Psychopharmacology. 33:502-510. 2019
- Age-related deficits in intracortical myelination in young adults with bipolar disorder type I. Journal of Psychiatry & Neuroscience. 44:79-88. 2019
- Bipolar disorder and 1513A>C P2RX7 polymorphism frequency. Neuroscience Letters. 694:143-147. 2019
- Subjective neurocognition and quality of life in patients with bipolar disorder and siblings. Journal of Affective Disorders. 245:283-288. 2019
- Is bipolar disorder associated with premature aging?. Trends in Psychiatry and Psychotherapy. 41:315-317. 2019
- Metabolic syndrome and psychiatric disorders: a population-based study. Revista Brasileira de Psiquiatria. 41:38-43. 2019
- Metabolic syndrome, depression and anhedonia among young adults. Psychiatry Research. 271:306-310. 2019
- Validation of the Korean Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry. Psychiatry Investigation. 15:1115-1120. 2018
- Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression. Acta Neuropsychiatrica. 30:334-341. 2018
- Emotional hyper‐reactivity and cardiometabolic risk in remitted bipolar patients: a machine learning approach. Acta Psychiatrica Scandinavica. 138:348-359. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review. Journal of Psychiatry & Neuroscience. 43:298-316. 2018
- Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review.. Journal of Psychiatry & Neuroscience. 43:298-316. 2018
- Volumetric brain magnetic resonance imaging predicts functioning in bipolar disorder: A machine learning approach. Journal of Psychiatric Research. 103:237-243. 2018
- Association of intracortical myelin and cognitive function in bipolar I disorder. Acta Psychiatrica Scandinavica. 138:62-72. 2018
- Oxidative stress markers imbalance in late-life depression. Journal of Psychiatric Research. 102:29-33. 2018
- The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study. Journal of Psychiatric Research. 102:186-191. 2018
- Risk Factors for Suicidality in Patients With Schizophrenia: A Systematic Review, Meta-analysis, and Meta-regression of 96 Studies. Schizophrenia Bulletin. 44:787-797. 2018
- Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder. Current Neuropharmacology. 16:519-532. 2018
- Case series of diagnostic shift from bipolar disorder to schizoaffective disorder. Nordic Journal of Psychiatry. 72:232-235. 2018
- Bipolar disorder and tobacco smoking: Categorical and dimensional clinical correlates in subjects from the Brazilian bipolar research network. Comprehensive Psychiatry. 82:14-21. 2018
- Cardiovascular risk and bipolar disorder: factors associated with a positive coronary calcium score in patients with bipolar disorder type 1. Revista Brasileira de Psiquiatria. 40:163-168. 2018
-
Canadian Network for Mood and Anxiety Treatments (
CANMAT ) and International Society for Bipolar Disorders (ISBD ) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. 20:97-170. 2018 - Construction of a biological rhythm assessment scale for children. Trends in Psychiatry and Psychotherapy. 40:53-60. 2018
- Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar Disorder. Clinical Psychopharmacology and Neuroscience. 16:103-108. 2018
- Mood disorders and prospective suicidality in young adults: a population‐based cohort study. Acta Psychiatrica Scandinavica. 137:109-115. 2018
- The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder. Journal of Affective Disorders. 227:214-218. 2018
- Correction: Potential use of text classification tools as signatures of suicidal behavior: A proof-of-concept study using Virginia Woolf's personal writings. PLoS ONE. 13:e0207963-e0207963. 2018
- EGR3 Immediate Early Gene and the Brain-Derived Neurotrophic Factor in Bipolar Disorder. Frontiers in Behavioral Neuroscience. 12:15. 2018
- Impact of resilience on the improvement of depressive symptoms after cognitive therapies for depression in a sample of young adults. Trends in Psychiatry and Psychotherapy. 40:226-231. 2018
- Intracellular Pathogen Infections and Immune Response in Autism. NeuroImmunoModulation. 25:271-279. 2018
- Potential use of text classification tools as signatures of suicidal behavior: A proof-of-concept study using Virginia Woolf’s personal writings. PLoS ONE. 13:e0204820-e0204820. 2018
- Staging, Neurocognition and Social Functioning in Bipolar Disorder. Frontiers in Psychiatry. 9:709. 2018
- Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0. Frontiers in Psychiatry. 9:641. 2018
- White matter volume is decreased in bipolar disorder at early and late stages. Trends in Psychiatry and Psychotherapy. 40:277-284. 2018
- Solar insolation in springtime influences age of onset of bipolar I disorder. Acta Psychiatrica Scandinavica. 136:571-582. 2017
- Sudden unexpected death in bipolar disorder. Journal of Affective Disorders. 223:8-9. 2017
- Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach. Schizophrenia Research. 188:182-184. 2017
- Analyzing leukocyte telomere length in bipolar disorder: Authors’ reply. Revista Brasileira de Psiquiatria. 39:275-276. 2017
- Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study. Journal of Psychiatric Research. 92:119-123. 2017
- The impact of machine learning techniques in the study of bipolar disorder: A systematic review. Neuroscience and Biobehavioral Reviews. 80:538-554. 2017
- Differences in biomarkers of crack-cocaine adolescent users before/after abstinence. Drug and Alcohol Dependence. 177:207-213. 2017
- Clinical staging and serum cytokines in bipolar patients during euthymia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 77:194-201. 2017
- Inflammation and internalizing disorders in adolescents. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 77:133-137. 2017
- Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder. Journal of Neuroimmunology. 307:33-36. 2017
- Telomere Length, Oxidative Stress, Inflammation and BDNF Levels in Siblings of Patients with Bipolar Disorder: Implications for Accelerated Cellular Aging. International Journal of Neuropsychopharmacology. 20:445-454. 2017
- The Bipolar Illness Onset study: research protocol for the BIO cohort study. BMJ Open. 7:e015462-e015462. 2017
- Functional impairment and cognitive performance in mood disorders: A community sample of young adults. Psychiatry Research. 251:85-89. 2017
- Neuroprogression and illness trajectories in bipolar disorder. Expert Review of Neurotherapeutics. 17:277-285. 2017
- “Why throw away something useful?”: Attitudes and opinions of people treated for bipolar disorder and their relatives on organ and tissue donation. Cell and Tissue Banking. 18:105-117. 2017
- Cytokine Levels in Panic Disorder: Evidence for a Dose-Response Relationship. Psychosomatic Medicine. 79:126-132. 2017
- Should bipolar disorder treatment be modified depending on staging?. Expert Review of Neurotherapeutics. 17:93-95. 2017
- Cell therapy in the treatment of bipolar mania in an animal model: a proof of concept study. Trends in Psychiatry and Psychotherapy. 39:196-201. 2017
- Changing the bipolar illness trajectory. The Lancet Psychiatry. 4:11-13. 2017
- Frequency of brain tissue donation for research after suicide. Revista Brasileira de Psiquiatria. 39:180-182. 2017
- Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study. Australian and New Zealand Journal of Psychiatry. 51:65-74. 2017
- Mood disorders and biological rhythms in young adults: A large population-based study. Journal of Psychiatric Research. 84:98-104. 2017
- Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review. Neuropsychiatric Disease and Treatment. Volume 13:1627-1632. 2017
- Virginia Woolf, neuroprogression, and bipolar disorder. Revista Brasileira de Psiquiatria. 39:69-71. 2017
- Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: A community study. Journal of Neuroimmunology. 301:23-29. 2016
- Peripheral adenosine levels in euthymic patients with bipolar disorder. Psychiatry Research. 246:421-426. 2016
- Concepts and misconceptions regarding clinical staging models. Journal of Psychiatry & Neuroscience. 41:E84-E85. 2016
- The Biological Rhythms Interview of Assessment in Neuropsychiatry in patients with bipolar disorder: correlation with affective temperaments and schizotypy. Revista Brasileira de Psiquiatria. 38:325-328. 2016
- Biological rhythms, metabolic syndrome and current depressive episode in a community sample. Psychoneuroendocrinology. 72:34-39. 2016
- Childhood trauma, family history, and their association with mood disorders in early adulthood. Acta Psychiatrica Scandinavica. 134:281-286. 2016
- Concepts and misconceptions regarding clinical staging models : Author response.. Journal of Psychiatry & Neuroscience. 41:E83-E84. 2016
- Reduced Neurite Density in Neuronal Cell Cultures Exposed to Serum of Patients with Bipolar Disorder. International Journal of Neuropsychopharmacology. 19:pyw051-pyw051. 2016
- Refractory bipolar disorder and neuroprogression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 70:103-110. 2016
- BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention‐deficit/hyperactivity disorder. Acta Psychiatrica Scandinavica. 134:268-274. 2016
- High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users. Neuroscience Letters. 630:169-175. 2016
- Staging model raises fundamental questions about the nature of bipolar disorder. Journal of Psychiatry & Neuroscience. 41:291-293. 2016
- Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatrica Scandinavica. 134:91-103. 2016
- Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia – A controlled cross-sectional study. Cytokine. 84:25-28. 2016
- Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial. Molecular Psychiatry. 21:1050-1056. 2016
- Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. Journal of Affective Disorders. 198:198-205. 2016
- The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets. Australian and New Zealand Journal of Psychiatry. 50:618-630. 2016
- Psychiatric and clinical correlates of rapid cycling bipolar disorder: a cross-sectional study. Revista Brasileira de Psiquiatria. 38:270-274. 2016
- Brain‐derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course. Bipolar Disorders. 18:373-378. 2016
- Predictors of psychiatric readmission among patients with bipolar disorder at an academic safety-net hospital. Australian and New Zealand Journal of Psychiatry. 50:584-593. 2016
- Clinical Outcomes Associated With Comorbid Posttraumatic Stress Disorder Among Patients With Bipolar Disorder. Journal of Clinical Psychiatry. 77:e555-e560. 2016
- Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3. Translational Psychiatry. 6:e805-e805. 2016
- Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression. International Journal of Neuropsychopharmacology. 19:pyv135-pyv135. 2016
- Antidepressants for generalised anxiety disorder (GAD). Clinical Respiratory Journal. 2016:CD003592. 2016
- Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach. Journal of Affective Disorders. 193:109-116. 2016
- Individualized Prediction and Clinical Staging of Bipolar Disorders Using Neuroanatomical Biomarkers. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 1:186-194. 2016
- Individualized identification of euthymic bipolar disorder using the Cambridge Neuropsychological Test Automated Battery (CANTAB) and machine learning. Journal of Affective Disorders. 192:219-225. 2016
- Post-traumatic stress disorder and interleukin 6 – Authors' reply. The Lancet Psychiatry. 3:202-202. 2016
- Antioxidant treatments for schizophrenia. Clinical Respiratory Journal. 2016:CD008919. 2016
- Hippocampal volume and verbal memory performance in late-stage bipolar disorder. Journal of Psychiatric Research. 73:102-107. 2016
- The association between biological rhythms, depression, and functioning in bipolar disorder: a large multi‐center study. Acta Psychiatrica Scandinavica. 133:102-108. 2016
- A Study of Biological Rhythm Disturbances in Polish Remitted Bipolar Patients using the BRIAN, CSM, and SWPAQ Scales. Neuropsychobiology. 74:125-130. 2016
- Big data analytics and machine learning: 2015 and beyond. The Lancet Psychiatry. 3:13-15. 2016
- Challenges and developments in research of the early stages of bipolar disorder. Revista Brasileira de Psiquiatria. 38:329-337. 2016
- Cognitive performance and psychosocial functioning in patients with bipolar disorder, unaffected siblings, and healthy controls. Revista Brasileira de Psiquiatria. 38:275-280. 2016
- Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine. Molecular Neurobiology. 53:611-620. 2016
- Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder. Revista Brasileira de Psiquiatria. 38:197-200. 2016
- Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease. Revista Brasileira de Psiquiatria. 38:281-286. 2016
- Developmental staging models in bipolar disorder. International Journal of Bipolar Disorders. 3:33. 2015
- Immune activation as a mediator of the gut-brain axis in manic episodes. Australian and New Zealand Journal of Psychiatry. 49:1223-1223. 2015
- Interaction between SLC6A4 promoter variants and childhood trauma on the age at onset of bipolar disorders. Scientific Reports. 5:16301. 2015
- Biological rhythms in bipolar and depressive disorders: A community study with drug-naïve young adults. Journal of Affective Disorders. 186:145-148. 2015
- Functioning in bipolar disorder with substance abuse/dependence in a community sample of young adults. Journal of Affective Disorders. 187:179-182. 2015
- Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry. 2:1002-1012. 2015
- Is bipolar disorder associated with accelerating aging? A meta-analysis of telomere length studies. Journal of Affective Disorders. 186:241-248. 2015
- Is religiosity a protective factor against suicidal behavior in bipolar I outpatients?. Journal of Affective Disorders. 186:156-161. 2015
- Rapid cycling bipolar disorder is associated with a higher lifetime prevalence of migraine. Acta Psychiatrica Scandinavica. 132:308-309. 2015
- Damage‐associated molecular patterns and immune activation in bipolar disorder. Acta Psychiatrica Scandinavica. 132:211-217. 2015
- Effects of a single bout of maximal aerobic exercise on BDNF in bipolar disorder: A gender-based response. Psychiatry Research. 229:57-62. 2015
- Ethanol during adolescence decreased the BDNF levels in the hippocampus in adult male Wistar rats, but did not alter aggressive and anxiety-like behaviors. Trends in Psychiatry and Psychotherapy. 37:143-151. 2015
- Memory and brain-derived neurotrophic factor after subchronic or chronic amphetamine treatment in an animal model of mania. Journal of Psychiatric Research. 68:329-336. 2015
- Mitochondrial and Oxidative Stress Aspects in Hippocampus of Rats Submitted to Dietary n-3 Polyunsaturated Fatty Acid Deficiency After Exposure to Early Stress. Neurochemical Research. 40:1870-1881. 2015
- Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review. Current Psychiatry Reports. 17:75. 2015
- Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies. Anais da Academia Brasileira de Ciencias. 87:1809-1818. 2015
- Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins. Molecular Neurobiology. 52:26-37. 2015
- Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania. Molecular Neurobiology. 52:353-362. 2015
- Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders. Anais da Academia Brasileira de Ciencias. 87:1435-1449. 2015
- The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 300:141-154. 2015
- Differences in parental bonding between schizophrenia and bipolar disorder: Evidence of prodromal symptoms?. Schizophrenia Research. 165:134-137. 2015
- Changes in the corpus callosum in women with late-stage bipolar disorder. Acta Psychiatrica Scandinavica. 131:458-464. 2015
- Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation. Neurochemical Research. 40:1144-1152. 2015
- Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder. Psychiatry Research. 227:372-373. 2015
- Brain‐derived neurotrophic factor and inflammatory markers in school‐aged children with early trauma. Acta Psychiatrica Scandinavica. 131:360-368. 2015
- Effects of sodium butyrate on aversive memory in rats submitted to sepsis. Neuroscience Letters. 595:134-138. 2015
- Folic acid prevented cognitive impairment in experimental pneumococcal meningitis. Journal of Neural Transmission. 122:643-651. 2015
- Influence of light exposure during early life on the age of onset of bipolar disorder. Journal of Psychiatric Research. 64:1-8. 2015
- Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate. Journal of Neural Transmission. 122:709-719. 2015
- C-Reactive Protein Alterations in Bipolar Disorder. Journal of Clinical Psychiatry. 76:142-150. 2015
- Psychophysiological correlates of cognitive deficits in family caregivers of patients with Alzheimer Disease. Neuroscience. 286:371-382. 2015
- Verbal episodic memory along the course of schizophrenia and bipolar disorder: A new perspective. European Neuropsychopharmacology. 25:169-175. 2015
- Hypothalamic-Pituitary-Adrenal Axis Dysfunction and Illness Progression in Bipolar Disorder. International Journal of Neuropsychopharmacology. 18:pyu043-pyu043. 2015
- The role of encoding strategies in contextual memory deficits in patients with bipolar disorder. Neuropsychological Rehabilitation. 25:122-136. 2015
- Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder. Revista Brasileira de Psiquiatria. 37:296-302. 2015
- Association of serum brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-alpha (TNF-α) with diagnosis of delirium in oncology inpatients. Revista Brasileira de Psiquiatria. 37:197-202. 2015
- Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. Revista Brasileira de Psiquiatria. 37:155-161. 2015
- Correlation between Peripheral Levels of Brain-Derived Neurotrophic Factor and Hippocampal Volume in Children and Adolescents with Bipolar Disorder. Neural Plasticity. 2015:1-7. 2015
- Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. European psychiatry. 30:99-105. 2015
- Quality of life, social functioning, family structure, and treatment history associated with crack cocaine use in youth from the general population. Revista Brasileira de Psiquiatria. 37:211-218. 2015
- Wet minds, dry minds, and the future of psychiatry as a science. Acta Psychiatrica Scandinavica. 131:7-8. 2015
- Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids in Health and Disease. 13:44. 2014
- Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. Journal of Psychiatric Research. 59:8-13. 2014
- Neurocognitive Functioning in Overweight and Obese Patients with Bipolar Disorder: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Canadian Journal of Psychiatry. 59:639-648. 2014
-
Staging systems in bipolar disorder: an
I nternationalS ociety forB ipolarD isordersT askF orceR eport. Acta Psychiatrica Scandinavica. 130:354-363. 2014 - Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 54:289-298. 2014
- Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Psychopharmacology. 231:4031-4039. 2014
- Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study. Journal of Affective Disorders. 167:104-111. 2014
- Shared clinical associations between obesity and impulsivity in rapid cycling bipolar disorder: A systematic review. Journal of Affective Disorders. 168:306-313. 2014
- Vitamin B6 prevents cognitive impairment in experimental pneumococcal meningitis. Experimental Biology and Medicine. 239:1360-1365. 2014
- Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. International Journal of Neuropsychopharmacology. 17:1453-1463. 2014
- Inflammatory mediators of cognitive impairment in bipolar disorder. Journal of Psychiatric Research. 56:18-27. 2014
- Neuroprogression and staging in psychiatry: historical considerations. Revista Brasileira de Psiquiatria. 36:187-188. 2014
- Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population. Comprehensive Psychiatry. 55:1369-1376. 2014
- Violent and sexual behaviors and lifetime use of crack cocaine: a population-based study in Brazil. Social Psychiatry and Psychiatric Epidemiology. 49:1249-1255. 2014
- Prevalence and clinical correlates of alcohol use disorders among bipolar disorder patients: Results from the Brazilian Bipolar Research Network. Comprehensive Psychiatry. 55:1116-1121. 2014
- Validation of the Italian Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN): Some Considerations on its Screening Usefulness. Clinical Practice and Epidemiology in Mental Health. 10:48-52. 2014
- Association between family history of mood disorders and clinical characteristics of bipolar disorder: Results from the Brazilian bipolar research network. Journal of Affective Disorders. 161:104-108. 2014
- Burden and related factors in caregivers of young adults presenting bipolar and unipolar mood disorder. International Journal of Social Psychiatry, The. 60:396-402. 2014
- Progesterone and its metabolites as therapeutic targets in psychiatric disorders. Expert Opinion on Therapeutic Targets. 18:679-690. 2014
- Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatrica Scandinavica. 129:437-444. 2014
- Clinical Staging in Bipolar Disorder. Journal of Clinical Psychiatry. 75:e450-e456. 2014
- Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial. Acta Psychiatrica Scandinavica. 129:393-400. 2014
- BDNF: A biomarker for social vulnerability in individuals diagnosed with gender dysphoria. Journal of Psychiatric Research. 50:16-17. 2014
- Effectiveness and tolerance of anti‐inflammatory drugs' add‐on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatrica Scandinavica. 129:163-179. 2014
- Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder. Journal of Affective Disorders. 152-154:474-477. 2014
- Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes. European psychiatry. 29:58-63. 2014
- Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania. Revista Brasileira de Psiquiatria. 36:39-46. 2014
- Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. International Journal of Neuropsychopharmacology. 17:33-40. 2014
- Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. Journal of Psychiatric Research. 48:13-15. 2014
- Socio-demographic and clinical characteristics of pregnant and puerperal crack-cocaine using women: preliminary data. Revista de Psiquiatria Clinica. 41:121-123. 2014
- [Bipolar disorder: staging and neuroprogression].. Psychiatria Polska. 48:231-243. 2014
- Biological rhythm disturbance in remitted bipolar patients. International Journal of Bipolar Disorders. 1:6. 2013
- Expression of matrix metalloproteinases in patients with bipolar disorder. Revista Brasileira de Psiquiatria. 35:375-379. 2013
- Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry. 13:27. 2013
- RBP and Brazilian science. Revista Brasileira de Psiquiatria. 35:337-337. 2013
- Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behavioural Brain Research. 256:451-456. 2013
- The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. American Journal of Psychiatry. 170:1249-1262. 2013
- Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. Journal of Psychiatric Research. 47:1396-1402. 2013
- Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. Journal of Psychiatric Research. 47:1546-1548. 2013
- Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. Revista Brasileira de Psiquiatria. 35:262-266. 2013
- Modafinil ameliorates cognitive deficits induced by maternal separation and sleep deprivation. Behavioural Brain Research. 253:274-279. 2013
- Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). Journal of Affective Disorders. 150:29-36. 2013
- Correlation of Acute Phase Inflammatory and Oxidative Markers With Long-term Cognitive Impairment in Sepsis Survivors Rats. Shock. 40:45-48. 2013
- Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Review of Neurotherapeutics. 13:827-842. 2013
- Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder. Revista Brasileira de Psiquiatria. 35:126-130. 2013
- Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Revista Brasileira de Psiquiatria. 35:157-160. 2013
- Peripheral toxicity in crack cocaine use disorders. Neuroscience Letters. 544:80-84. 2013
- The quest for better diagnosis: DSM-5 or RDoC?. Revista Brasileira de Psiquiatria. 35:109-110. 2013
- Vulnerability to dietary n-3 polyunsaturated fatty acid deficiency after exposure to early stress in rats. Pharmacology Biochemistry and Behavior. 107:11-19. 2013
- Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Australian and New Zealand Journal of Psychiatry. 47:321-332. 2013
- Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. The British journal of psychiatry. Supplement. 202:243-245. 2013
- Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder. Acta Neuropsychiatrica. 25:101-104. 2013
- Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats. Behavioural Brain Research. 242:40-46. 2013
- Soft Bipolar Spectrum and Staging in Bipolar Disorder. Current Psychiatry Research and Reviews. 9:33-40. 2013
- Staging and Neuroprogression in Bipolar Disorder: A Systematic Review of the Literature. Revista Brasileira de Psiquiatria. 35:70-74. 2013
- Bipolar Disorder Affects Behavior and Social Skills on the Internet. PLoS ONE. 8:e79673-e79673. 2013
- Early Life Stress Interacts with the Diet Deficiency of Omega-3 Fatty Acids during the Life Course Increasing the Metabolic Vulnerability in Adult Rats. PLoS ONE. 8:e62031-e62031. 2013
- Early trauma and mood disorders in youngsters. Revista de Psiquiatria Clinica. 40:93-96. 2013
- Erratum: Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels. Translational Psychiatry. 3:e225-e225. 2013
- Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Current Opinion in Psychiatry. 26:19-26. 2013
- Teamwork is our legacy. Trends in Psychiatry and Psychotherapy. 35:1-2. 2013
- The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder. European psychiatry. 28:21-29. 2013
- Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia. Value in Health Regional Issues. 1:244-247. 2012
- Early functional impairment in bipolar youth: A nested population-based case-control study. Journal of Affective Disorders. 142:208-212. 2012
- Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial. BMC Medicine. 10:91. 2012
- Screening for bipolar disorder in the primary care: A Brazilian survey. Journal of Affective Disorders. 143:118-124. 2012
- Staging and Neuroprogression in Bipolar Disorder. Current Psychiatry Reports. 14:667-675. 2012
- Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model. Pharmacology Biochemistry and Behavior. 103:395-402. 2012
- Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels. Translational Psychiatry. 2:e195-e195. 2012
- Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder. Journal of Psychiatric Research. 46:1511-1514. 2012
- Stigma experiences in bipolar patients: the impact upon functioning. Journal of Psychiatric and Mental Health Nursing. 19:665-671. 2012
- The Relevance of Neuroscience Research Networks for Brazilian Science. Revista Brasileira de Psiquiatria. 34:119-120. 2012
- Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disorders. 14:654-663. 2012
- Memory mood congruency phenomenon in bipolar I disorder and major depression disorder patients. Brazilian Journal of Medical and Biological Research. 45:856-861. 2012
- Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. International Journal of Neuropsychopharmacology. 15:1043-1050. 2012
- Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. Journal of Affective Disorders. 140:82-91. 2012
- Anatomical faces of neuroprogression in bipolar disorder. Neuropsychiatry. 2:279-280. 2012
- Cognitive impairment in school-aged children with early trauma. Comprehensive Psychiatry. 53:758-764. 2012
- Effects of experimental cerebral malaria in memory, brain-derived neurotrophic factor and acetylcholinesterase acitivity in the hippocampus of survivor mice. Neuroscience Letters. 523:104-107. 2012
- Impact of comorbid migraine on the clinical course of bipolar disorder. Comprehensive Psychiatry. 53:809-812. 2012
- Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid. Journal of Neural Transmission. 119:627-637. 2012
- Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metabolic Brain Disease. 27:175-182. 2012
- Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. Journal of Psychiatric Research. 46:819-824. 2012
- Neurobiological correlates of illness progression in the recurrent affective disorders. Journal of Psychiatric Research. 46:561-573. 2012
- Childhood trauma, impulsivity, and executive functioning in crack cocaine users. Comprehensive Psychiatry. 53:238-244. 2012
- Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatrica Scandinavica. 125:303-308. 2012
- Mediators of allostasis and systemic toxicity in bipolar disorder. Physiology and Behavior. 106:46-50. 2012
- Increased levels of adipokines in bipolar disorder. Journal of Psychiatric Research. 46:389-393. 2012
- Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy. Revista Brasileira de Psiquiatria. 34:119-120. 2012
- Prevalence and clinical impact of eating disorders in bipolar patients. Revista Brasileira de Psiquiatria. 34:66-70. 2012
- A Bidimensional Solution for Outcomes in Bipolar Disorder. Journal of Nervous and Mental Disease. 200:180-182. 2012
- Imipramine treatment reverses depressive‐like behavior in alloxan‐diabetic rats. Diabetes/Metabolism Research and Reviews. 28:139-144. 2012
- Is there an association between suicide attempt and delay of initiation of mood stabilizers in bipolar I disorder?. Journal of Affective Disorders. 136:1082-1087. 2012
- Protein Kinase C and Oxidative Stress in an Animal Model of Mania. Current Neurovascular Research. 9:47-57. 2012
- Social phobia in Brazilian university students: Prevalence, under-recognition and academic impairment in women. Journal of Affective Disorders. 136:857-861. 2012
- Decreased BDNF levels in amygdala and hippocampus after intracerebroventricular administration of ouabain. Revista de Psiquiatria Clinica. 39:157-160. 2012
- Dopamine sudden depletion as a model for mixed depression. Medical Hypotheses. 78:107-112. 2012
- Marcadores periféricos e a fisiopatologia do transtorno bipolar. Revista de Psiquiatria Clinica. 39:60-67. 2012
- Behavioral and neurochemical effects of sodium butyrate in an animal model of mania. Behavioural Pharmacology. 22:766-772. 2011
- Effects of increased opportunity for physical exercise and learning experiences on recognition memory and brain-derived neurotrophic factor levels in brain and serum of rats. Neuroscience. 199:284-291. 2011
- N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs?. Revista Brasileira de Psiquiatria. 33:321-322. 2011
- The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. Journal of Affective Disorders. 135:389-394. 2011
- The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Revista Brasileira de Psiquiatria. 33:352-361. 2011
- The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Revista Brasileira de Psiquiatria. 33:353-361. 2011
- Assessment of Executive Functions in a Brazilian Sample of Bipolar Subjects. Spanish Journal of Psychology, The. 14:859-868. 2011
- Six‐month functional outcome of a bipolar disorder cohort in the context of a specialized‐care program. Bipolar Disorders. 13:679-686. 2011
- Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala. Acta Neuropsychiatrica. 23:241-248. 2011
- Early life stress decreases hippocampal BDNF content and exacerbates recognition memory deficits induced by repeated d-amphetamine exposure. Behavioural Brain Research. 224:100-106. 2011
- Systemic toxicity in early-stage mood disorders. Journal of Psychiatric Research. 45:1407-1409. 2011
- Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Revista Brasileira de Psiquiatria. 33:268-274. 2011
- Symptom Dimensional Approach and BDNF in Unmedicated Obsessive-Compulsive Patients: An Exploratory Study. CNS Spectrums. 16:179-189. 2011
- Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. Journal of Psychiatric Research. 45:995-1004. 2011
- The identification of unipolar mania subtype based on anxiety comorbidity. Journal of Affective Disorders. 132:356-359. 2011
- Corrigendum to “Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania”. Pharmacology Biochemistry and Behavior. 99:112-112. 2011
- Insulin dysfunction and allostatic load in bipolar disorder. Expert Review of Neurotherapeutics. 11:1017-1028. 2011
- Risk of suicide and mixed episode in men in the postpartum period. Journal of Affective Disorders. 132:243-246. 2011
- Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Review of Neurotherapeutics. 11:1029-1047. 2011
- Creatine kinase levels in patients with bipolar disorder: depressive, manic, and euthymic phases. Revista Brasileira de Psiquiatria. 33:171-175. 2011
- Improvement of behavioural and manic-like symptoms secondary to herpes simplex virus encephalitis with mood stabilizers: a case report. International Journal of Neuropsychopharmacology. 14:718-720. 2011
- Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors. Molecular Neurobiology. 43:207-214. 2011
- Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex. Neuroscience Letters. 497:99-103. 2011
- Sleep and Circadian Rhythm Disturbances in Bipolar Disorder. Journal of Clinical Psychiatry. 72:724-724. 2011
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. Neuropsychopharmacology. 36:1219-1226. 2011
- Association study of tryptophan hydroxylase 2 gene polymorphisms in bipolar disorder patients with panic disorder comorbidity. Psychiatric Genetics. 21:106-111. 2011
- Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. Journal of Critical Care. 26:133-137. 2011
- Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. Journal of Psychiatric Research. 45:495-504. 2011
- Stigma and functioning in patients with bipolar disorder. Journal of Affective Disorders. 130:323-327. 2011
- Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania. Pharmacology Biochemistry and Behavior. 98:304-310. 2011
- Maternal Deprivation Induces Depressive-like Behaviour and Alters Neurotrophin Levels in the Rat Brain. Neurochemical Research. 36:460-466. 2011
- Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation. Neuroscience Letters. 491:207-210. 2011
- Total and Mitochondrial Nitrosative Stress, Decreased Brain-Derived Neurotrophic Factor (BDNF) Levels and Glutamate Uptake, and Evidence of Endoplasmic Reticulum Stress in the Hippocampus of Vitamin A-Treated Rats. Neurochemical Research. 36:506-517. 2011
- Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychopharmacology. 25:274-280. 2011
- Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research. 45:156-161. 2011
- Peripheral biomarkers and illness activity in bipolar disorder. Journal of Psychiatric Research. 45:156-161. 2011
- Should bipolar disorder be considered a systemic illness?. Neuropsychiatry. 1:45-54. 2011
- Acute low dose of MK-801 prevents memory deficits without altering hippocampal DARPP-32 expression and BDNF levels in sepsis survivor rats. Journal of Neuroimmunology. 230:48-51. 2011
- New title: Trends in Psychiatry and Psychotherapy. Trends in Psychiatry and Psychotherapy. 33:133-134. 2011
- Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews. 35:804-817. 2011
- Functional Impairment and Disability across Mood States in Bipolar Disorder. Value in Health. 13:984-988. 2010
- Improvement of schizophrenia with electroconvulsive therapy and serum brain‐derived neurotrophic factor levels: Lack of association in a pilot study. Psychiatry and Clinical Neurosciences. 64:663-665. 2010
- Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission. 117:1131-1137. 2010
- Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. Journal of Psychiatric Research. 44:903-909. 2010
- Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice. Journal of Psychiatric Research. 44:775-780. 2010
- From neuroprogression to neuroprotection: implications for clinical care. Medical Journal of Australia. 193:S36-S40. 2010
- From neuroprogression to neuroprotection: implications for clinical care.. Medical Journal of Australia. 193:S36-S40. 2010
- A systemic toxicity index developed to assess peripheral changes in mood episodes. Molecular Psychiatry. 15:784-786. 2010
- Correlates and impact of obsessive-compulsive comorbidity in bipolar disorder. Comprehensive Psychiatry. 51:353-356. 2010
- Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. Journal of Psychiatric Research. 44:561-565. 2010
- Circadian preference in bipolar disorder. Sleep and Breathing. 14:153-155. 2010
- Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Research. 1337:85-94. 2010
- Correlation between behavioral deficits and decreased brain-derived neurotrofic factor in neonatal meningitis. Journal of Neuroimmunology. 223:73-76. 2010
- Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. Journal of Psychiatric Research. 44:506-510. 2010
- Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels. Neuroscience. 167:969-973. 2010
- The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. Journal of Affective Disorders. 123:71-76. 2010
- The impact of staging bipolar disorder on treatment outcome of family psychoeducation. Journal of Affective Disorders. 123:81-86. 2010
- Effects of moderate exercise on cigarette smoke exposure-induced hippocampal oxidative stress values and neurological behaviors in mice. Neuroscience Letters. 475:16-19. 2010
- Association of polymorphisms of the tryptophan hydroxylase 2 gene with risk for bipolar disorder or suicidal behavior. Journal of Psychiatric Research. 44:271-274. 2010
- Depressive-Like Parameters in Sepsis Survivor Rats. Neurotoxicity Research. 17:279-286. 2010
- Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?. Brain Research Bulletin. 81:585-589. 2010
- Obesity is associated with previous suicide attempts in bipolar disorder. Acta Neuropsychiatrica. 22:63-67. 2010
- Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34:459-462. 2010
- Validity of the Portuguese version of the Bipolar Depression Rating Scale. Acta Neuropsychiatrica. 22:100-101. 2010
- BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells. Journal of Molecular Neuroscience. 40:303-310. 2010
- Effects of a gastrin-releasing peptide receptor antagonist on d-amphetamine-induced oxidative stress in the rat brain. Journal of Neural Transmission. 117:309-316. 2010
- Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties. Brain Research Bulletin. 81:491-496. 2010
- Functional impact of biological rhythm disturbance in bipolar disorder. Journal of Psychiatric Research. 44:220-223. 2010
- Instituto Nacional de Ciência e Tecnologia em Medicina Translacional (INCT-TM): abordagens metodológicas. Revista Brasileira de Psiquiatria. 32:83-90. 2010
- BDNF/TrkB Content and Interaction with Gastrin-Releasing Peptide Receptor Blockade in Colorectal Cancer. Oncology. 79:430-439. 2010
- Resistência à insulina e síndrome metabólica em pacientes ambulatoriais com transtorno do humor bipolar. Revista de Psiquiatria Clinica. 37:81-84. 2010
- The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder. Psychiatry Investigation. 7:243-243. 2010
- Bipolar disorder and age-related functional impairment. Revista Brasileira de Psiquiatria. 31:354-357. 2009
- Birth‐cohort and dual diagnosis effects on age‐at‐onset in Brazilian patients with bipolar I disorder. Acta Psychiatrica Scandinavica. 120:492-495. 2009
- Problems with single‐factor solutions in factor analyses of low‐end scores. Bipolar Disorders. 11:900-900. 2009
- The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers. Acta Neuropsychiatrica. 21:272-274. 2009
- Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder. Brain, Behavior, and Immunity. 23:1079-1082. 2009
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:1425-1430. 2009
- Epidemiology and Management of Anxiety in Patients with Bipolar Disorder. CNS Drugs. 23:953-964. 2009
- The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:1366-1371. 2009
- Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis. Journal of Psychiatric Research. 43:1200-1204. 2009
- Brazil launches an innovative program to develop the National Institutes for Science and Technology (INCTs): the INCT for Translational Medicine. Revista Brasileira de Psiquiatria. 31:197-199. 2009
- Cognitive function and serum levels of brain‐derived neurotrophic factor in patients with bipolar disorder. Bipolar Disorders. 11:663-671. 2009
- Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. Journal of Psychiatric Research. 43:1171-1174. 2009
- Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. Journal of Affective Disorders. 116:214-217. 2009
- Psychometric properties of the Parkinson's Disease Sleep Scale – Brazilian version. Parkinsonism and Related Disorders. 15:495-499. 2009
- Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice. Neuroscience Letters. 459:66-68. 2009
- The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disorders. 11:453-473. 2009
- 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.. Journal of Psychiatry & Neuroscience. 34:263-271. 2009
- Clinical implications of a staging model for bipolar disorders. Expert Review of Neurotherapeutics. 9:957-966. 2009
- Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Revista Brasileira de Psiquiatria. 31:136-140. 2009
- Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disorders. 11:401-409. 2009
- Marcadores de estrés oxidativo en el trastorno bipolar: un metaanálisis. Psiquiatria Biologica. 16:60-69. 2009
- Pilot-project of implantation of pharmaceutical care close to the program of bipolar mood disorder of the Hospital of Clinics of Porto Alegre. Brazilian Journal of Pharmaceutical Sciences. 45:249-256. 2009
- Reduced NGF Secretion by HT-29 Human Colon Cancer Cells Treated with a GRPR Antagonist. Protein and Peptide Letters. 16:650-652. 2009
- Use of contraceptive methods among women treated for bipolar disorder. Archives of Women's Mental Health. 12:183-185. 2009
- Validity of a Short Functioning Test (FAST) in Brazilian Outpatients with Bipolar Disorder. Value in Health. 12:624-627. 2009
- Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. International Journal of Neuropsychopharmacology. 12:447-447. 2009
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders. 11:225-255. 2009
- Sleep in bipolar patients. Sleep and Breathing. 13:169-173. 2009
- Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives. Journal of Affective Disorders. 114:1-13. 2009
- Increased serum neurotrophin-4/5 levels in bipolar disorder. Journal of Psychiatric Research. 43:721-723. 2009
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:450-455. 2009
- Predictores clínicos del funcionamiento interpersonal en pacientes bipolares. Revista de Psiquiatria y Salud Mental. 2:83-88. 2009
- Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients. Neuroscience Letters. 453:195-198. 2009
- Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neuroscience Letters. 452:111-113. 2009
- Brain‐derived neurotrophic factor in bipolar disorder: beyond trait and state: comment on ‘Decreased levels of serum brain‐derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders’. Bipolar Disorders. 11:221-222. 2009
- Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. Journal of Affective Disorders. 113:285-290. 2009
- Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. International Journal of Neuropsychopharmacology. 12:137-137. 2009
- Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of d-amphetamine. Brain Research. 1249:162-172. 2009
- Lower rates of comorbidities in euthymic bipolar patients. World Journal of Biological Psychiatry. 10:474-479. 2009
- Lower rates of comorbidities in euthymic bipolar patients. World Journal of Biological Psychiatry. 10:474-479. 2009
- Chronic Administration of Ketamine Elicits Antidepressant‐Like Effects in Rats without Affecting Hippocampal Brain‐Derived Neurotrophic Factor Protein Levels. Basic and Clinical Pharmacology and Toxicology. 103:502-506. 2008
- Cognitive impairment in a Brazilian sample of patients with bipolar mood disorder (vol 30, pg 209, 2008). Revista Brasileira de Psiquiatria. 30:432-432. 2008
- Functional impairment and previous suicide attempts in bipolar disorder. Acta Neuropsychiatrica. 20:300-306. 2008
- Increased oxidative stress as a mechanism for the decreased levels of BDNF in acute manic episodes (vol 30, pg 243, 2008). Revista Brasileira de Psiquiatria. 30:432-432. 2008
- Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders. 111:135-144. 2008
- Peripheral nucleotide hydrolysis in rats submitted to a model of electroconvulsive therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:1829-1833. 2008
- Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation. Revista Brasileira de Psiquiatria. 30:337-340. 2008
- Transtorno mental, indicadores demográficos e satisfação com a vida. Revista de Saude Publica. 42:1060-1066. 2008
- Chronic Mild Stress Paradigm Reduces Sweet Food Intake in Rats without Affecting Brain Derived Neurotrophic Factor Protein Levels. Current Neurovascular Research. 5:207-213. 2008
- Effects of mood stabilizers on DNA damage in an animal model of mania.. Journal of Psychiatry & Neuroscience. 33:516-524. 2008
- Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:1677-1681. 2008
- Cognitive impairment in a Brazilian sample of patients with bipolar disorder. Revista Brasileira de Psiquiatria. 30:209-214. 2008
- Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels. Journal of Neural Transmission. 115:1251-1255. 2008
- Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Revista Brasileira de Psiquiatria. 30:243-245. 2008
- Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder. Journal of Affective Disorders. 110:75-83. 2008
- Prevalência de transtornos mentais em indivíduos de uma unidade de referência para Programa Saúde da Família em Santa Cruz do Sul, Rio Grande do Sul, Brasil. Cadernos de Saude Publica. 24:2043-2053. 2008
- The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol. 42:451-457. 2008
- A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania. Journal of Clinical Psychiatry. 69:1237-1245. 2008
- Cognitive Performance and Quality of Life in Bipolar Disorder. Canadian Journal of Psychiatry. 53:517-524. 2008
- Decreased serum neurotrophin 3 in chronically medicated schizophrenic males. Neuroscience Letters. 440:197-201. 2008
- Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. 258:300-304. 2008
- Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:1595-1598. 2008
- TNF-α as a molecular target in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:1355-1361. 2008
- Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Review of Neurotherapeutics. 8:1101-1113. 2008
- Transtornos mentais em comunidade atendida pelo Programa Saúde da Família. Cadernos de Saude Publica. 24:1641-1650. 2008
- Emotional memory in bipolar disorder. The British journal of psychiatry. Supplement. 192:458-463. 2008
- Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats. Metabolic Brain Disease. 23:213-219. 2008
- Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica. 20:112-116. 2008
- When illness does not get better: do we need a palliative psychiatry?. Acta Neuropsychiatrica. 20:165-166. 2008
- Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:1064-1068. 2008
- Reply. Acta Psychiatrica Scandinavica. 117:398-399. 2008
- Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. Journal of Psychiatric Research. 42:416-421. 2008
- Predominant polarity in bipolar disorder: Diagnostic implications. Journal of Affective Disorders. 107:45-51. 2008
- Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neuroscience Letters. 433:270-273. 2008
- Avaliação de desempenho do Self-Reporting Questionnaire como instrumento de rastreamento psiquiátrico: um estudo comparativo com o Structured Clinical Interview for DSM-IV-TR. Cadernos de Saude Publica. 24:380-390. 2008
- Brain creatine kinase activity in an animal model of mania. Life Sciences. 82:424-429. 2008
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32:140-144. 2008
- Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neuroscience and Biobehavioral Reviews. 32:675-692. 2008
- Functional Impairment in Patients with Remitted Bipolar Disorder. Psychotherapy and Psychosomatics. 77:390-392. 2008
- Intense Exercise Induces Mitochondrial Dysfunction in Mice Brain. Neurochemical Research. 33:51-58. 2008
- [Neurocognitive functioning in euthymic patients with bipolar type I disorder].. Acta Medica Portuguesa. 21:527-538. 2008
- Mismatch between self-reported quality of life and functional assessment in acute mania: A matter of unawareness of illness?. Journal of Affective Disorders. 103:247-252. 2007
- Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatrica Scandinavica, Supplement. 116:41-49. 2007
- Mitochondrial IV complex and brain neurothrophic derived factor responses of mice brain cortex after downhill training. Neuroscience Letters. 426:171-174. 2007
- DNA damage in bipolar disorder. Psychiatry Research. 153:27-32. 2007
- Manic symptoms and quality of life in bipolar disorder. Psychiatry Research. 153:33-38. 2007
- Oxidative Stress and S100B Protein in Cirrhotic Children. Neurochemical Research. 32:1600-1603. 2007
- Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research. 41:523-529. 2007
- The role of hippocampus in the pathophysiology of bipolar disorder. Behavioural Pharmacology. 18:419-430. 2007
- DNA damage in rats after treatment with methylphenidate. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1282-1288. 2007
- A gastrin-releasing peptide receptor antagonist blocks d-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. Peptides. 28:1447-1452. 2007
- Basic Fibroblast Growth Factor Prevents the Memory Impairment Induced by Gastrin-Releasing Peptide Receptor Antagonism in Area CA1 of the Rat Hippocampus. Neurochemical Research. 32:1381-1386. 2007
- Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo1H MRS study. Bipolar Disorders. 9:119-127. 2007
- Late-Onset Neuroleptic Malignant Syndrome in a Patient Using Olanzapine. Journal of Clinical Psychopharmacology. 27:303-304. 2007
- Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects. Neuroscience Letters. 421:33-36. 2007
- Quem lê (mas não cita) ciência brasileira?. Revista Brasileira de Psiquiatria. 29:198-198. 2007
- Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neuroscience Letters. 420:45-48. 2007
- The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders. Recent Patents on CNS Drug Discovery. 2:125-129. 2007
- Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disorders. 9:128-135. 2007
- Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:887-891. 2007
- Immunoassay for glial fibrillary acidic protein: Antigen recognition is affected by its phosphorylation state. Journal of Neuroscience Methods. 162:282-286. 2007
- Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behavioural Pharmacology. 18:205-212. 2007
- Anxiety Comorbidity and Quality of Life in Bipolar Disorder Patients. Canadian Journal of Psychiatry. 52:175-181. 2007
- Polypharmacy and suicide attempts in bipolar disorder. Revista Brasileira de Psiquiatria. 29:35-38. 2007
- Polypharmacy and suicide attempts in bipolar disorder. Revista Brasileira de Psiquiatria. 29:35-38. 2007
- Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neuroscience Letters. 415:87-89. 2007
- Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Molecular Psychiatry. 12:230-231. 2007
- Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:217-224. 2007
- Decreased Plasma Brain Derived Neurotrophic Factor Levels in Unmedicated Bipolar Patients During Manic Episode. Biological Psychiatry. 61:142-144. 2007
- Fluvoxamina no transtorno depressivo maior: um estudo multicêntrico aberto. Jornal Brasileiro de Psiquiatria. 56:17-22. 2007
- Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:283-285. 2007
- Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clinical Practice and Epidemiology in Mental Health. 3:5-5. 2007
- Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters. 407:146-150. 2006
- Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.. Journal of Psychiatry & Neuroscience. 31:326-332. 2006
- Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:1231-1234. 2006
- Azapirones for generalized anxiety disorder. Clinical Respiratory Journal. 2015:CD006115. 2006
- Bipolar depression: the importance of being on remission. Revista Brasileira de Psiquiatria. 28:93-96. 2006
- Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sciences. 79:281-286. 2006
- Glial fibrillary acidic protein expression after electroconvulsive shocks in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:663-667. 2006
- Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disorders. 8:275-280. 2006
- Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Research. 1097:224-229. 2006
- Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behavioural Pharmacology. 17:311-318. 2006
- Acute and chronic electroconvulsive shock in rats: Effects on peripheral markers of neuronal injury and glial activity. Life Sciences. 78:3013-3017. 2006
- Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania. Neurochemical Research. 31:699-703. 2006
- Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: A study of patients treated with haloperidol or clozapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30:512-515. 2006
- Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters. 398:215-219. 2006
- Bipolar disorder: building the path of return to the ideas of Kraepelin. Revista Brasileira de Psiquiatria. 28:82-82. 2006
- [Mogens Schou and the use of lithium in psychiatry].. Revista Brasileira de Psiquiatria. 28:82-83. 2006
- An Open Trial of Adjunctive Escitalopram in Bipolar Depression. Journal of Clinical Psychiatry. 67:81-86. 2006
- Adaptation and validation of the Portuguese version of the Lithium Knowledge Test (LKT) of bipolar patients treated with lithium: cross-over study.. Clinical Practice and Epidemiology in Mental Health. 2:34-34. 2006
- Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over study.. Clinical Practice and Epidemiology in Mental Health. 2:32-32. 2006
- An open trial of reboxetine in obese patients with binge eating disorder. Eating and Weight Disorders. 10:e93-e96. 2005
- CANMAT guidelines for bipolar disorder: a commentary from South America. Bipolar Disorders. 7:87-88. 2005
- Clinical impact of late diagnose of bipolar disorder. Journal of Affective Disorders. 86:313-316. 2005
- Pharmacological treatment of bipolar disorder: Evidence from randomized clinical trials. Revista de Psiquiatria Clinica. 32:34-38. 2005
- A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Human Psychopharmacology. 20:133-139. 2005
- Diagnóstico precoce do Transtorno Bipolar. Revista Brasileira de Psiquiatria. 27:83-84. 2005
- The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis. Revista Brasileira de Psiquiatria. 27:18-24. 2005
- Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Research. 1028:213-218. 2004
- Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain. Life Sciences. 76:805-811. 2004
- Comorbidade com transtornos de ansiedade em transtorno bipolar. Revista Brasileira de Psiquiatria. 26:31-36. 2004
- Fisiopatologia do transtorno afetivo bipolar: o que mudou nos últimos 10 anos?. Revista Brasileira de Psiquiatria. 26:17-21. 2004
- Anormalidades neuropatológicas e neuroquímicas no transtorno afetivo bipolar. Revista Brasileira de Psiquiatria. 26:180-188. 2004
- Seasonal distribution and demographical characteristics of carpal tunnel syndrome in 1039 patients. Arquivos de Neuro-Psiquiatria. 62:596-599. 2004
- Psicoterapia psicodinâmica em grupo para fobia social generalizada. Revista Brasileira de Psiquiatria. 26:77-81. 2004
- Perspectives for the development of animal models of bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28:209-224. 2004
- [Comment about "Who pays for the impact?"].. Revista Brasileira de Psiquiatria. 25:261-262. 2003
- [Ethical aspects involving patient selection in psychiatric research].. Revista Brasileira de Psiquiatria. 25:259. 2003
- Apresentação. Revista Brasileira de Psiquiatria. 25:1-2. 2003
- Differential involvement of hippocampal and amygdalar NMDA receptors in contextual and aversive aspects of inhibitory avoidance memory in rats. Brain Research. 975:207-213. 2003
- Effects of Gabapentin on Anxiety Induced by Simulated Public Speaking. Journal of Psychopharmacology. 17:184-188. 2003
- Transtorno de estresse pós-traumático: critérios diagnósticos. Revista Brasileira de Psiquiatria. 25:3-7. 2003
- An Open Trial of Reboxetine in HIV-Seropositive Outpatients With Major Depressive Disorder. Journal of Clinical Psychiatry. 64:421-424. 2003
- Differential effects of emotional arousal in short- and long-term memory in healthy adults. Neurobiology of Learning and Memory. 79:132-135. 2003
- The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. European Journal of Nuclear Medicine and Molecular Imaging. 30:423-426. 2003
- Dose-related effects of propericiazine in rats. Brazilian Journal of Medical and Biological Research. 36:227-231. 2003
- Antidepressants for generalised anxiety disorder (GAD). Cochrane Database of Systematic Reviews. CD003592. 2003
- Cognitive-Behavioral Group Therapy in Obsessive-Compulsive Disorder: A Randomized Clinical Trial. Psychotherapy and Psychosomatics. 72:211-216. 2003
- Interaction between midazolam-induced anterograde amnesia and memory enhancement by treatments given immediately after training on an inhibitory avoidance task in rats. Behavioural Pharmacology. 13:319-322. 2002
- Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. European Neuropsychopharmacology. 12:269-272. 2002
- The Serum S100B Concentration Is Age Dependent. Clinical Chemistry. 48:950-952. 2002
- The serum S100B concentration is age dependent. Clinical Chemistry. 48:950-952. 2002
- Purinergic dysfunction in mania: an integrative model. Medical Hypotheses. 58:297-304. 2002
- Behavioural effects of acute phenylalanine and tyrosine depletion in healthy male volunteers. Journal of Psychopharmacology. 16:51-55. 2002
- Therapeutic Efficacy of Allopurinol in Mania Associated With Hyperuricemia. Journal of Clinical Psychopharmacology. 21:621-622. 2001
- Mirtazapine versus fluoxetine in the treatment of panic disorder. Brazilian Journal of Medical and Biological Research. 34:1303-1307. 2001
- Mania Associated with an Energy Drink: The Possible Role of Caffeine, Taurine, and Inositol. Canadian Journal of Psychiatry. 46:454-455. 2001
- Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves†. Phytotherapy Research. 15:162-164. 2001
- USE AND MISUSE OF BENZODIAZEPINES IN BRAZIL: A REVIEW. Substance Use and Misuse. 36:1053-1069. 2001
- Evoked Potentials for the Evaluation of Latent Hepatic Encephalopathy in Pediatric Liver Transplant Candidates. Journal of Pediatric Gastroenterology and Nutrition. 31:371-376. 2000
- The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats. Behavioural Pharmacology. 11:169-173. 2000
- Behavioural effects of acute tryptophan depletion in healthy male volunteers. Journal of Psychopharmacology. 14:157-163. 2000
- Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse. 34:124-134. 1999
- Brain uptake of iomazenil in cirrhotic patients: a single photon emission tomography study. Journal of Psychopharmacology. 13:219-225. 1999
- Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?. Journal of Psychopharmacology. 13:318-319. 1999
- Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis. Hepatology. 29:1338-1338. 1999
- Drugs acting at the glycine site on the NMDA receptor as cognitive enhancers in patients with Alzheimer's disease. Neurology. 50:1195-1195. 1998
- Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors.. Journal of Neurology, Neurosurgery and Psychiatry. 60:676-680. 1996
- Mild depression levels alter self-perceptions of future but not the recall of verbal information in elderly inpatients.. Brazilian Journal of Medical and Biological Research. 29:259-265. 1996
- FLUMAZENIL HAS AN ANXIOLYTIC EFFECT IN SIMULATED STRESS (VOL 114, PG 187, 1994). Psychopharmacology. 121:284-284. 1995
- Central benzodiazepine receptor imaging and quantitation with single photon emission computerised tomography: SPECT. Journal of Psychopharmacology. 9:369-380. 1995
- Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients. Psychopharmacology. 120:220-226. 1995
- Flumazenil has an anxiolytic effect in simulated stress. Psychopharmacology. 114:187-189. 1994
- Observing Countertransference in Brief Dynamic Psychotherapy. Psychotherapy and Psychosomatics. 56:174-181. 1991
- Memory modulation by post-training intraperitoneal, but not intracerebroventricular, administration of ACTH or epinephrine. Behavioral and Neural Biology. 39:277-283. 1983